| 产品名称： | 8A2N |
|---|---|
| 商品货号： | TS212768 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with type O, Rh- human erythrocytes and purified glycophorin A. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against glycophorin A type N |
| Cellular Products： | immunoglobulin; monoclonal antibody; against glycophorin A type N |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in immunosuppressed BALB/c mice |
| Comments： | Animals were immunized with type O, Rh- human erythrocytes and purified glycophorin A. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody does not react with type M glycophorin A. |
| Complete Growth Medium： | Culture Medium: Dulbeccos modified Eagles medium, 90%; fetal bovine serum, 10%. |
| Subculturing： | Medium Renewal: 2 to 3 times per week Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 1 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | Culture medium, 70%; heat-inactivated fetal bovine serum, 20%; DMSO, 10% |
| Isotype： | IgG1; kappa light chain |
| Name of Depositor： | Lawrence Livermore National Lab |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number： | <a href="~/ref.aspx?_id=3CAE9218ABB44DB5858236D06606412C&_rf=rf">ref</a>"> (Bigbee WL, et al. Cell lines for the production of monoclonal antibodies to human glycophorin A. US Patent 4,767,710 dated Aug 30 1988) |
| References： | Bigbee WL, et al. Monoclonal antibodies specific for the M-and N-forms of human glycophorin A. Mol. Immunol. 20: 1353-1362, 1983. PubMed: 6197636 Bigbee WL, et al. Binding specificities of eight monoclonal antibodies to human glycophorin A. Studies with McM, and MkEn(UK) variant human erythrocytes and M- and MNv-type chimpanzee erythrocytes. J. Immunol. 133: 3149-3155, 1984. PubMed: 6491283 Bigbee WL, et al. Cell lines for the production of monoclonal antibodies to human glycophorin A. US Patent 4,767,710 dated Aug 30 1988 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | 8A2N |
|---|---|
| 商品货号： | TS212768 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with type O, Rh- human erythrocytes and purified glycophorin A. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against glycophorin A type N |
| Cellular Products： | immunoglobulin; monoclonal antibody; against glycophorin A type N |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in immunosuppressed BALB/c mice |
| Comments： | Animals were immunized with type O, Rh- human erythrocytes and purified glycophorin A. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody does not react with type M glycophorin A. |
| Complete Growth Medium： | Culture Medium: Dulbeccos modified Eagles medium, 90%; fetal bovine serum, 10%. |
| Subculturing： | Medium Renewal: 2 to 3 times per week Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 1 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | Culture medium, 70%; heat-inactivated fetal bovine serum, 20%; DMSO, 10% |
| Isotype： | IgG1; kappa light chain |
| Name of Depositor： | Lawrence Livermore National Lab |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number： | <a href="~/ref.aspx?_id=3CAE9218ABB44DB5858236D06606412C&_rf=rf">ref</a>"> (Bigbee WL, et al. Cell lines for the production of monoclonal antibodies to human glycophorin A. US Patent 4,767,710 dated Aug 30 1988) |
| References： | Bigbee WL, et al. Monoclonal antibodies specific for the M-and N-forms of human glycophorin A. Mol. Immunol. 20: 1353-1362, 1983. PubMed: 6197636 Bigbee WL, et al. Binding specificities of eight monoclonal antibodies to human glycophorin A. Studies with McM, and MkEn(UK) variant human erythrocytes and M- and MNv-type chimpanzee erythrocytes. J. Immunol. 133: 3149-3155, 1984. PubMed: 6491283 Bigbee WL, et al. Cell lines for the production of monoclonal antibodies to human glycophorin A. US Patent 4,767,710 dated Aug 30 1988 |
